You are here

COVID-19 vaccine: News and updates

17 January 2021

Read the latest COVID-19 vaccine news and other updates from the Therapeutic Goods Administration (TGA).

Norwegian investigation of COVID-19 vaccination risks for elderly, very frail patients
17 January 2021
In recent days the TGA has received reports of about 30 deaths in over 40,000 elderly individuals in Norway vaccinated with the Pfizer BioNTech vaccine.

Access Consortium statement on COVID-19 vaccines evidence
4 December 2020
The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom have discussed the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post-market pharmacovigilance.

TGA statement on UK government emergency use authorisation related to the COVID-19 vaccine BNT162b2 supplied by Pfizer and BioNTech
2 December 2020
The TGA notes the emergency use authorisation related to the COVID-19 vaccine BNT162b2 supplied by Pfizer and BioNTech.

COVID-19 vaccines undergoing evaluation
2 December 2020
The TGA has received applications and is assessing preliminary data for three COVID-19 vaccines using the provisional pathway and rolling review procedures.

COVID-19 vaccine provisional determinations
18 November 2020
The TGA has granted a number of provisional determinations in relation to COVID-19 vaccines.

TGA grants third provisional determination for a COVID-19 vaccine
18 November 2020
On 16 November 2020 the TGA granted a provisional determination to Janssen in relation to its COVID-19 vaccine, Ad26.COV2.S.

TGA grants second provisional determination for a COVID-19 vaccine
14 October 2020
The TGA has granted a provisional determination to Pfizer Australia Pty Ltd in relation to its COVID-19 Vaccine, BNT162b2 [mRNA].

TGA grants provisional determination for COVID-19 vaccine
9 October 2020
The TGA has granted a provisional determination to AstraZeneca Pty Ltd in relation to its COVID-19 Vaccine, ChAd0x1-S [recombinant].